We recently compiled a list of the 7 Stocks on Jim Cramer’s Radar. In this article, we are going to take a look at where Eli ...

Weight-loss drugs are transforming both health care and Wall Street, with leading manufacturers like Eli Lilly & Co. (LLY) ...

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

Eli Lilly unexpectedly lowered its full-year 2024 guidance. The miss appears to stem from a lack of the typical December ...

Allurion catapulted nearly 200% early Friday after the company said it plans to test its weight-loss technology with an ...

“Recently, Eli Lilly announced the results from its SURMOUNT ... for these treatments hailed for their ability to help people lose weight. The Biden administration in November moved to require ...

Leerink Partners analyst David Risinger maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) on January 24 and set a price ...

Eli Lilly started 2024 on a strong note but struggled during the second half of the year. The drugmaker dealt with several ...

Eli Lilly has been riding the weight-loss drug ... Regardless of what they are approved for, however, many non-obese people are using these drugs to lose weight. One example is the already ...